PUBLICATION

Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia

Authors
Marin-Valencia, I., Gerondopoulos, A., Zaki, M.S., Ben-Omran, T., Almureikhi, M., Demir, E., Guemez-Gamboa, A., Gregor, A., Issa, M.Y., Appelhof, B., Roosing, S., Musaev, D., Rosti, B., Wirth, S., Stanley, V., Baas, F., Barr, F.A., Gleeson, J.G.
ID
ZDB-PUB-170822-8
Date
2017
Source
American journal of human genetics   101(3): 441-450 (Journal)
Registered Authors
Baas, Frank
Keywords
TBC1D23, ataxia, intellectual disability, microcephaly, pontocerebellar hypoplasia
MeSH Terms
  • Adolescent
  • Animals
  • Cerebellar Diseases/genetics*
  • Cerebellar Diseases/pathology
  • Child
  • Child, Preschool
  • Female
  • GTPase-Activating Proteins/genetics*
  • HeLa Cells
  • Homozygote*
  • Humans
  • Male
  • Microcephaly/genetics*
  • Microcephaly/pathology
  • Mutation*
  • Pedigree
  • Phenotype
  • Zebrafish/genetics
  • Zebrafish/growth & development
PubMed
28823706 Full text @ Am. J. Hum. Genet.
Abstract
Pontocerebellar hypoplasia (PCH) represents a group of recessive developmental disorders characterized by impaired growth of the pons and cerebellum, which frequently follows a degenerative course. Currently, there are 10 partially overlapping clinical subtypes and 13 genes known mutated in PCH. Here, we report biallelic TBC1D23 mutations in six individuals from four unrelated families manifesting a non-degenerative form of PCH. In addition to reduced volume of pons and cerebellum, affected individuals had microcephaly, psychomotor delay, and ataxia. In zebrafish, tbc1d23 morphants replicated the human phenotype showing hindbrain volume loss. TBC1D23 localized at the trans-Golgi and was regulated by the small GTPases Arl1 and Arl8, suggesting a role in trans-Golgi membrane trafficking. Altogether, this study provides a causative link between TBC1D23 mutations and PCH and suggests a less severe clinical course than other PCH subtypes.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping